• Most Popular
  • Most Shared

Zeltia's Yondelis gets approval in Philippines

Fri Jul 10, 2009 2:44am EDT

Stocks

   

MADRID, July 10 (Reuters) - Spain's Zeltia (ZEL.MC) said on Friday its Yondelis drug had been approved for the treatment of recurrent ovarian cancer in The Philippines.

It marked the first approval of its kind for the company in the treatment of this disease, Zeltia said.

Yondelis, made by Zeltia's Pharma Mar unit, was also given the green light for the treatment of advanced soft tissue sarcoma in adults, it said. (Reporting by Elisabeth O'Leary; Editing by Andrew Hay)



More from Reuters

Photo

Microsoft loses Word patent appeal

SEATTLE (Reuters) - A U.S. court of appeals on Tuesday upheld a $290 million jury verdict against Microsoft Corp for infringing a patent held by a small Canadian software firm, and affirmed an injunction that prevents Microsoft from selling versions of its Word program which contain the offending software.

» More Top News
Guadalupe Hernandez receives an ultrasound by nurse practitioner Gail Brown during a prenatal exam at the Maternity Outreach Mobile in Phoenix, Arizona October 8, 2009. Credit: REUTERS/Joshua Lott

Health reform inches closer

Democrats are on the verge of passing landmark legislation by Christmas, with only one more hurdle remaining.  Full Article | Video 

Healthcare Reform
Investors walk at the Dubai Financial Market December 21, 2009. REUTERS/Mosab Omar
Analysis:

Dubai, it's time to get creative

Scrambling to rebuild its image after a $26 billion debt bombshell, Dubai needs to raise cash without the PR nightmare of raising taxes.  Full Article 

Global Markets